1. Home
  2. RDW vs LQDA Comparison

RDW vs LQDA Comparison

Compare RDW & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDW
  • LQDA
  • Stock Information
  • Founded
  • RDW 2020
  • LQDA 2004
  • Country
  • RDW United States
  • LQDA United States
  • Employees
  • RDW N/A
  • LQDA N/A
  • Industry
  • RDW Military/Government/Technical
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDW Industrials
  • LQDA Health Care
  • Exchange
  • RDW Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • RDW 1.5B
  • LQDA 1.2B
  • IPO Year
  • RDW N/A
  • LQDA 2018
  • Fundamental
  • Price
  • RDW $15.59
  • LQDA $12.06
  • Analyst Decision
  • RDW Buy
  • LQDA Strong Buy
  • Analyst Count
  • RDW 7
  • LQDA 9
  • Target Price
  • RDW $17.46
  • LQDA $27.67
  • AVG Volume (30 Days)
  • RDW 4.4M
  • LQDA 2.7M
  • Earning Date
  • RDW 08-06-2025
  • LQDA 08-06-2025
  • Dividend Yield
  • RDW N/A
  • LQDA N/A
  • EPS Growth
  • RDW N/A
  • LQDA N/A
  • EPS
  • RDW N/A
  • LQDA N/A
  • Revenue
  • RDW $277,704,000.00
  • LQDA $14,144,000.00
  • Revenue This Year
  • RDW $44.20
  • LQDA $185.38
  • Revenue Next Year
  • RDW $46.78
  • LQDA $350.95
  • P/E Ratio
  • RDW N/A
  • LQDA N/A
  • Revenue Growth
  • RDW 1.36
  • LQDA N/A
  • 52 Week Low
  • RDW $4.87
  • LQDA $8.26
  • 52 Week High
  • RDW $26.66
  • LQDA $19.41
  • Technical
  • Relative Strength Index (RSI)
  • RDW 48.39
  • LQDA 33.97
  • Support Level
  • RDW $15.09
  • LQDA $11.85
  • Resistance Level
  • RDW $17.57
  • LQDA $13.83
  • Average True Range (ATR)
  • RDW 1.27
  • LQDA 0.72
  • MACD
  • RDW -0.45
  • LQDA -0.22
  • Stochastic Oscillator
  • RDW 14.29
  • LQDA 6.95

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: